News
Vanda ends 40-year hiatus for new motion sickness drugs
The FDA has delivered some end-of-year cheer to Vanda Pharma after approving Nereus, its drug for the prevention of motion sickness.
News
Judge blocks HHS' 340B rebate pilot at 11th hour
A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.
News
No Christmas present for Sanofi, as FDA turns down MS drug
FDA has turned down Sanofi's oral BTK inhibitor tolebrutinib for multiple sclerosis, despite suggesting earlier it would delay a decision until 2026.
News
Biosimilars unlock use of bevacizumab in bowel cancer by NHS
More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.
News
CMS aims for broader GLP-1 access via federal programmes
CMS has revealed a new, voluntary access programme that aims to broaden the use of GLP-1 agonist medicines for diabetes and obesity.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
